LYHER Obtained ANVISA Approval for Dengue NS1 Antigen Test Kit in Brazil！

101 words | Last Updated: 2026-03-05 | By Dr. Aaron Chen
Dr. Aaron Chen - author
Author: Dr. Aaron Chen
Dr. Aaron Chen is a veteran medical scientist with 12+ years of experience in clinical diagnostics and POCT. He leads research in rapid test innovations, driving breakthroughs in high-sensitivity colloidal gold and immunofluorescence assays.
LYHER Obtained ANVISA Approval for Dengue NS1 Antigen Test Kit in Brazil！
Table of Contents

  

blobid0.png

We are excited to share that ANVISA has officially published the approval of our LYHER® Dengue NS1 Antigen Test Kit (Registration No. 80686360439), paving the way for legal marketing and distribution across Brazil.

 

This milestone reinforces our commitment to providing reliable and accessible diagnostic solutions globally.

 

Product highlights:

Samples: Whole blood / Serum / Plasma

Pack size: 25 tests per kit

Performance: 95.65% sensitivity | 98.26% specificity

 

If you are interested in exploring potential business collaboration and want to know more product details, please feel free to contact us at office@lyher.com.

 

We look forward to hearing from you.